Publication:
FANCD2 Facilitates Replication through Common Fragile Sites.

dc.contributor.authorMadireddy, Advaitha
dc.contributor.authorKosiyatrakul, Settapong T
dc.contributor.authorBoisvert, Rebecca A
dc.contributor.authorHerrera-Moyano, Emilia
dc.contributor.authorGarcía-Rubio, María L
dc.contributor.authorGerhardt, Jeannine
dc.contributor.authorVuono, Elizabeth A
dc.contributor.authorOwen, Nichole
dc.contributor.authorYan, Zi
dc.contributor.authorOlson, Susan
dc.contributor.authorAguilera, Andrés
dc.contributor.authorHowlett, Niall G
dc.contributor.authorSchildkraut, Carl L
dc.date.accessioned2023-01-25T08:38:17Z
dc.date.available2023-01-25T08:38:17Z
dc.date.issued2016
dc.description.abstractCommon fragile sites (CFSs) are genomic regions that are unstable under conditions of replicative stress. Although the characteristics of CFSs that render them vulnerable to stress are associated mainly with replication, the cellular pathways that protect CFSs during replication remain unclear. Here, we identify and describe a role for FANCD2 as a trans-acting facilitator of CFS replication, in the absence of exogenous replicative stress. In the absence of FANCD2, replication forks stall within the AT-rich fragility core of CFS, leading to dormant origin activation. Furthermore, FANCD2 deficiency is associated with DNA:RNA hybrid formation at CFS-FRA16D, and inhibition of DNA:RNA hybrid formation suppresses replication perturbation. In addition, we also found that FANCD2 reduces the number of potential sites of replication initiation. Our data demonstrate that FANCD2 protein is required to ensure efficient CFS replication and provide mechanistic insight into how FANCD2 regulates CFS stability.
dc.identifier.doi10.1016/j.molcel.2016.09.017
dc.identifier.essn1097-4164
dc.identifier.pmcPMC5683400
dc.identifier.pmid27768874
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683400/pdf
dc.identifier.unpaywallURLhttp://www.cell.com/article/S1097276516305664/pdf
dc.identifier.urihttp://hdl.handle.net/10668/10551
dc.issue.number2
dc.journal.titleMolecular cell
dc.journal.titleabbreviationMol Cell
dc.language.isoen
dc.organizationCentro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER
dc.page.number388-404
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, N.I.H., Extramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectDNA replication
dc.subjectDNA:RNA hybrids
dc.subjectFanconi anemia
dc.subjectcancer
dc.subjectcommon fragile sites
dc.subjectgenomic instability
dc.subject.meshBRCA2 Protein
dc.subject.meshCell Line, Transformed
dc.subject.meshChromosome Fragile Sites
dc.subject.meshDNA
dc.subject.meshDNA Replication
dc.subject.meshFanconi Anemia
dc.subject.meshFanconi Anemia Complementation Group A Protein
dc.subject.meshFanconi Anemia Complementation Group D2 Protein
dc.subject.meshFanconi Anemia Complementation Group Proteins
dc.subject.meshFibroblasts
dc.subject.meshGene Expression
dc.subject.meshGenomic Instability
dc.subject.meshHerpesvirus 4, Human
dc.subject.meshHumans
dc.subject.meshLymphocytes
dc.subject.meshRNA
dc.titleFANCD2 Facilitates Replication through Common Fragile Sites.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number64
dspace.entity.typePublication

Files